Novartis AG Snags Fougera for $1.5 Billion for Generic Skin Drugs

Novartis AG (NOVN), Europes largest drugmaker, said it will spend $1.5 billion for closely held Fougera Pharmaceuticals Inc. in a deal to become the top seller of generic skin medications. Fougera, ba…
Read the full story: BioSpace.com Featured News